Valiant Laboratories (BOM:543998) Total Liabilities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Total Liabilities?

Valiant Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Valiant Laboratories's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹1,293.46 Mil) but then declined from Sep. 2024 (₹1,293.46 Mil) to Dec. 2024 (₹0.00 Mil).

Valiant Laboratories's annual Total Liabilities increased from Mar. 2022 (₹1,103.52 Mil) to Mar. 2023 (₹1,124.75 Mil) but then declined from Mar. 2023 (₹1,124.75 Mil) to Mar. 2024 (₹1,058.26 Mil).

Valiant Laboratories Total Liabilities Historical Data

The historical data trend for Valiant Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Total Liabilities Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Liabilities

177.32

1,103.52

1,124.75

1,058.26

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial							-	1,058.26	-	1,293.46	-

Valiant Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Valiant Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	290.769	+	(750.899	+	15.793
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0.8	+	0)
	=	1,058

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	3426.873	-	2368.612
	=	1,058

Valiant Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Valiant Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Total Liabilities

Traded in Other Exchanges

VALIANTLAB:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines